Survivor Profile Breaking Down Barriers Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research. by Bradley Jones More Data on COVID-19 Vaccination and Cancer Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients. by Anna Goshua Chemobrain: It’s Not Your Imagination Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021. by Marci A. Landsmann Searching the Blood for Signs of Altered Immunity The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors. by Kate Yandell A Drive for Diversity African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that. by Jon Kelvey Forward Look Watch Your Mouth Dental screening before treatment could stave off dental emergencies. by Nancy Averett Q&A The Lost Poetry of Patient Stories Medical histories capture a vital snapshot of a patient’s health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative. by Marci A. Landsmann Keeping CLL in Check With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease. by Kendall K. Morgan Get Involved Filling a Void A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers. by Elizabeth Rosto Sitko Despite Generic Imatinib, Cost of Treating CML Remains High The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds. by Anna Azvolinsky next Cancer Talk Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks More Posts